Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Berg, JL; Perfler, B; Hatzl, S; Uhl, B; Reinisch, A; Pregartner, G; Berghold, A; Penz, T; Schuster, M; Geissler, K; Prokesch, A; Müller-Tidow, C; Hoefler, G; Kashofer, K; Wölfler, A; Sill, H; Caraffini, V; Zebisch, A.
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
Leukemia. 2021; 35(5):1521-1526
Doi: 10.1038/s41375-021-01161-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Berg Johannes Lorenz
- Zebisch Armin
- Co-Autor*innen der Med Uni Graz
- Berghold Andrea
- Caraffini Veronica
- Hatzl Stefan
- Höfler Gerald
- Kashofer Karl
- Perfler Bianca
- Pregartner Gudrun
- Prokesch Andreas
- Reinisch Andreas
- Sill Heinz
- Uhl Barbara
- Wölfler Albert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Carcinogenesis - genetics
- Cell Line, Tumor - administration & dosage
- Enhancer of Zeste Homolog 2 Protein - genetics
- HL-60 Cells - administration & dosage
- Humans - administration & dosage
- Leukemia, Myelomonocytic, Chronic - drug therapy, genetics
- Mitogen-Activated Protein Kinase Kinases - genetics
- Myeloid Cells - drug effects
- Protein Kinase Inhibitors - pharmacology
- Signal Transduction - genetics
- ras Proteins - genetics